Globus Medical (GMED) Shares Outstanding (Diluted Average) (2011 - 2026)

Globus Medical (GMED) has 14 years of Shares Outstanding (Diluted Average) data on file, last reported at $138.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 1.13% year-over-year to $138.2 million; the trailing twelve-month figure through Mar 2026 stood at $138.2 million (down 1.13% YoY), and the FY2025 full-year result was $137.1 million, down 0.59% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $138.2 million, up from $137.1 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $139.8 million in Q1 2025 and bottomed at $114.6 million in Q4 2023.
• The 4-year median for Shares Outstanding (Diluted Average) is $137.9 million (2024), against an average of $133.5 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) increased 20.27%; it then dropped 1.13% in 2026.
• A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $114.6 million in 2023, then advanced by 20.27% to $137.9 million in 2024, then slipped by 0.59% to $137.1 million in 2025, then increased by 0.83% to $138.2 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $138.2 million (Q1 2026), $137.1 million (Q4 2025), and $139.8 million (Q1 2025), per Business Quant data.

Peer Comparison